Medifast (MED) Revenue (2010 - 2026)

Medifast's Revenue history runs 17 years deep, the most recent figure standing at $76.0 million for Q1 2026.

• Quarterly Revenue fell 34.29% year-over-year to $76.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $346.1 million (down 36.31% YoY) and the FY2025 annual result came in at $385.8 million, down 35.96% from the prior year.
• Revenue was $76.0 million for Q1 2026 at Medifast, up from $75.1 million in the prior quarter.
• Across five years, Revenue topped out at $453.3 million in Q2 2022 and bottomed at $75.1 million in Q4 2025.
• A 5-year average of $219.7 million and a median of $174.7 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue gained 22.58% — and 2024, when it tumbled 49.93%.
• Medifast's Revenue stood at $337.2 million in 2022, then plunged by 43.36% to $191.0 million in 2023, then plunged by 37.7% to $119.0 million in 2024, then slumped by 36.9% to $75.1 million in 2025, then rose by 1.26% to $76.0 million in 2026.
• Business Quant data shows MED's Revenue at $76.0 million in Q1 2026, $75.1 million in Q4 2025, and $89.4 million in Q3 2025.